FOEHR MATTHEW W
SEC insider (Form 3/4/5 filer). CIK 0001237556. President and CEO at OmniAb, Inc. (OABI) and 1 other issuer. 30 reported Form 4/5 transactions since Sep 2024; latest on Apr 7, 2026. Located in EMERYVILLE, CA.
Companies FOEHR MATTHEW W has filed insider reports for
- OmniAb, Inc. (OABI): Director, Officer, President and CEO
- Viking Therapeutics, Inc. (VKTX): Director
FOEHR MATTHEW W
CIK: 0001237556
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (30 total)
- Apr 7, 2026OABI
OmniAb, Inc.
SaleDirect19.2K shares at avg. $1.49$29K - Apr 7, 2026OABI
OmniAb, Inc.
ExerciseDirect36.5K shares- - Feb 18, 2026OABI
OmniAb, Inc.
AwardDirectRestricted Stock Units
156.3K shares- - Feb 18, 2026OABI
OmniAb, Inc.
AwardDirectStock Option
1.6M shares- - Feb 18, 2026OABI
OmniAb, Inc.
SaleDirect30.8K shares at avg. $1.71$53K - Feb 18, 2026OABI
OmniAb, Inc.
ExerciseDirect58.3K shares- - Feb 17, 2026OABI
OmniAb, Inc.
SaleDirect20.8K shares at avg. $1.70$35K - Feb 16, 2026OABI
OmniAb, Inc.
ExerciseDirect36.5K shares- - Jan 2, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect3.2K shares- - Jan 2, 2026VKTX
Viking Therapeutics, Inc.
ExerciseDirect16K shares at avg. $3.33$53K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 7, 2026 |  OABI OmniAb, Inc. | Sale | 19,244 | $1.49 | $28,674 | Direct |
| Apr 7, 2026 | OABI OmniAb, Inc. | Exercise | 36,459 | - | $0 | Direct |
| Feb 18, 2026 | OABI OmniAb, Inc. | Award Restricted Stock Units | 156,250 | - | - | Direct |
| Feb 18, 2026 | OABI OmniAb, Inc. | Award Stock Option | 1,562,500 | - | - | Direct |
| Feb 18, 2026 | OABI OmniAb, Inc. | Sale | 30,843 | $1.71 | $52,742 | Direct |
| Feb 18, 2026 | OABI OmniAb, Inc. | Exercise | 58,333 | - | $0 | Direct |
| Feb 17, 2026 | OABI OmniAb, Inc. | Sale | 20,754 | $1.70 | $35,282 | Direct |
| Feb 16, 2026 | OABI OmniAb, Inc. | Exercise | 36,458 | - | $0 | Direct |
| Jan 2, 2026 |  VKTX Viking Therapeutics, Inc. | Award | 3,150 | - | $0 | Direct |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Exercise | 16,000 | $3.33 | $53,280 | Direct |
1-10 of 30 transactions